HHS Supports Repatriation of U.S. Citizens to Specialized Care Facilities - Scorecard - MDSpire

HHS Facilitates Return of U.S. Citizens to Specialized Medical Facilities

  • By

  • Assistant Secretary for Public Affairs (ASPA)

  • May 10, 2026

Share

Clinical Scorecard: HHS Facilitates Return of U.S. Citizens to Specialized Medical Facilities

At a Glance

CategoryDetail
ConditionHantavirus Infection (Andes Variant)
Key MechanismsTransmission primarily through contact with infected rodents or their excreta; rare person-to-person transmission.
Target PopulationAmerican citizens exposed to the Andes variant of hantavirus aboard the MV Hondius cruise ship.
Care SettingASPR Regional Emerging Special Pathogen Treatment Centers and other specialized medical facilities.

Key Highlights

  • Coordination between HHS, ASPR, CDC, and the Department of State for repatriation efforts.
  • Deployment of specialized medical resources for assessment and care of affected individuals.
  • Low overall risk to the American public from the Andes variant of hantavirus.

Guideline-Based Recommendations

Diagnosis

  • Clinical assessment upon arrival at treatment facilities.

Management

  • Provide appropriate care and support based on individual conditions.

Monitoring & Follow-up

  • Contact tracing and exposure assessment coordinated by state health departments.

Risks

  • Transmission is rare and limited to close-contact settings.

Patient & Prescribing Data

Individuals repatriated from the MV Hondius cruise ship.

Care tailored to individual clinical assessments upon arrival at specialized treatment centers.

Clinical Best Practices

  • Utilize specialized treatment centers for hantavirus exposure cases.
  • Implement public health guidance and risk assessments from the CDC.

Related Resources & Content

Original Source(s)

HHS Supports Repatriation of U.S. Citizens to Specialized Care Facilities

  • by Assistant Secretary for Public Affairs (ASPA)

  • May 10, 2026

Related Content

First HIV-Positive-to-HIV-Positive Lung Transplant Reported

The procedure was performed under a HOPE Act research protocol at an NYU Langone Health center the institution said is among the limited number of US transplant centers equipped and approved to perform HOPE lung transplants.

Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI

Weekly HIV Regimen Meets Phase 3 Goal

The investigational combination pairs islatravir and lenacapavir in a once-weekly single-tablet regimen.